Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko et al.|Hepatology|2019Cited by 119
Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acidMasao Iwao, Hirotaka Shibata, Koro Gotoh et al.|Scientific Reports|2020Cited by 64
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control studyKosuke Matsumoto, Atsushi Tanaka, Satoko Ohfuji et al.|Journal of Gastroenterology|2021Cited by 34
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitisMinami Yagi, Kosuke Matsumoto, Atsumasa Komori et al.|Liver International|2020Cited by 21
<i>α</i>‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver diseaseMasanori Tokoro, Hirotaka Shibata, Koro Gotoh et al.|Obesity Science & Practice|2020Cited by 14